MeiraGTx (MGTX) stock rose 7% after publishing promising results from the first human trial using gene therapy to treat AIPL1-associated severe retinal dystrophy in children. Across all trials so far, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback